Cadence Bank NA’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-8,719
| Closed | -$672K | – | 54 |
|
|
2022
Q2 | $672K | Sell |
8,719
-431
| -5% | -$32.8K | 0.22% | 102 |
|
|
2022
Q1 | $668K | Buy |
9,150
+877
| +11% | +$58.9K | 0.19% | 117 |
|
|
2021
Q4 | $516K | Sell |
8,273
-154
| -2% | -$9.03K | 0.14% | 134 |
|
|
2021
Q3 | $499K | Buy |
8,427
+59
| +0.7% | +$3.88K | 0.15% | 131 |
|
|
2021
Q2 | $559K | Sell |
8,368
-144
| -2% | -$9.39K | 0.17% | 126 |
|
|
2021
Q1 | $538K | Sell |
8,512
-615
| -7% | -$38.3K | 0.17% | 125 |
|
|
2020
Q4 | $566K | Sell |
9,127
-2,940
| -24% | -$181K | 0.2% | 115 |
|
|
2020
Q3 | $728K | Sell |
12,067
-605
| -5% | -$36.4K | 0.28% | 86 |
|
|
2020
Q2 | $745K | Buy |
12,672
+342
| +3% | +$20.5K | 0.32% | 78 |
|
|
2020
Q1 | $688K | Sell |
12,330
-946
| -7% | -$57.8K | 0.35% | 74 |
|
|
2019
Q4 | $852K | Buy |
13,276
+3,785
| +40% | +$217K | 0.31% | 89 |
|
|
2019
Q3 | $481K | Sell |
9,491
-818
| -8% | -$38.4K | 0.19% | 121 |
|
|
2019
Q2 | $468K | Sell |
10,309
-197
| -2% | -$9.18K | 0.18% | 120 |
|
|
2019
Q1 | $501K | Sell |
10,506
-1,003
| -9% | -$50K | 0.2% | 113 |
|
|
2018
Q4 | $598K | Sell |
11,509
-498
| -4% | -$26.8K | 0.27% | 94 |
|
|
2018
Q3 | $745K | Sell |
12,007
-243
| -2% | -$14.4K | 0.28% | 99 |
|
|
2018
Q2 | $678K | Sell |
12,250
-65
| -0.5% | -$3.51K | 0.28% | 97 |
|
|
2018
Q1 | $779K | Sell |
12,315
-309
| -2% | -$19.9K | 0.31% | 91 |
|
|
2017
Q4 | $774K | Sell |
12,624
-2,351
| -16% | -$147K | 0.28% | 93 |
|
|
2017
Q3 | $955K | Sell |
14,975
-1,835
| -11% | -$107K | 0.36% | 82 |
|
|
2017
Q2 | $937K | Buy |
16,810
+364
| +2% | +$19.8K | 0.43% | 66 |
|
|
2017
Q1 | $894K | Buy |
16,446
+173
| +1% | +$9.49K | 0.41% | 65 |
|
|
2016
Q4 | $951K | Buy |
16,273
+130
| +0.8% | +$7.11K | 0.45% | 60 |
|
|
2016
Q3 | $871K | Sell |
16,143
-283
| -2% | -$18.2K | 0.39% | 57 |
|
|
2016
Q2 | $1.21M | Buy |
16,426
+393
| +2% | +$27.8K | 0.59% | 52 |
|
|
2016
Q1 | $1.02M | Buy |
16,033
+164
| +1% | +$10.3K | 0.53% | 53 |
|
|
2015
Q4 | $1.09M | Buy |
15,869
+94
| +0.6% | +$6.21K | 0.58% | 46 |
|
|
2015
Q3 | $934K | Sell |
15,775
-365
| -2% | -$23.2K | 0.54% | 52 |
|
|
2015
Q2 | $1.07M | Sell |
16,140
-314
| -2% | -$20.7K | 0.7% | 27 |
|
|
2015
Q1 | $1.06M | Buy |
16,454
+485
| +3% | +$30.4K | 0.59% | 36 |
|
|
2014
Q4 | $943K | Sell |
15,969
-51
| -0.3% | -$2.88K | 0.5% | 38 |
|
|
2014
Q3 | $820K | Buy |
16,020
+149
| +0.9% | +$7.44K | 0.44% | 43 |
|
|
2014
Q2 | $770K | Buy |
15,871
+1,355
| +9% | +$66.8K | 0.41% | 49 |
|
|
2014
Q1 | $755K | Buy |
14,516
+905
| +7% | +$48.2K | 0.45% | 43 |
|
|
2013
Q4 | $723K | Buy |
13,611
+819
| +6% | +$41.7K | 0.39% | 55 |
|
|
2013
Q3 | $592K | Buy |
12,792
+589
| +5% | +$25.9K | 0.36% | 56 |
|
|
2013
Q2 | $545K | Buy |
+12,203
| New | +$530K | 0.3% | 60 |
|
Other funds holding BMY
Cadence Bank NA's BMY Position: Q3 2022 in Review
Cadence Bank NA sold out of Bristol-Myers Squibb (BMY) in Q3 2022, closing a stake of 8,719 shares — an estimated $672K sold.
Cadence Bank NA first reported a position in BMY in Q2 2013 and held it in 37 quarters. The position peaked at $1.21M in Q2 2016. 2,469 funds tracked by Wall St. Rank hold BMY as of Q3 2022.
- Cadence Bank NA reported no remaining Bristol-Myers Squibb position as of Q3 2022 after selling out during the quarter.
- Cadence Bank NA sold 8,719 Bristol-Myers Squibb shares in Q3 2022, an estimated $672K.
- Cadence Bank NA first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 37 quarters.
- Cadence Bank NA's Bristol-Myers Squibb position peaked at $1.21M in Q2 2016.
- 2,469 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2022.
Based on Cadence Bank NA's 13F filing for Q3 2022, filed 27 Oct 2022.